×
The Standard e-Paper
Fearless, Trusted News
The Standard Group Plc is a
multi-media organization with investments in media platforms spanning newspaper
print operations, television, radio broadcasting, digital and online services. The
Standard Group is recognized as a leading multi-media house in Kenya with a key
influence in matters of national and international interest.
Novartis is taking aim at drug-resistant malaria – a growing global problem – by launching clinical trials of the first new antimalarial medicine for many years in nine countries across Africa and Asia.
The Swiss drugmaker, which is working on the mid-stage Phase IIb trial program with the group Medicines for Malaria Venture (MMV), said on Monday it believed its drug KAF156 could be a "game-changer".
Subscribe to our newsletter and stay updated on the latest developments and special offers!
join